http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103251610-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc04cbe597b38449dcb758bfddb8f9a0 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-537 |
| filingDate | 2013-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103251610-A |
| titleOfInvention | Application of Aspeverin in preparation of anti-platelet aggregation medicines |
| abstract | The invention relates to an application of Aspeverin in preparation of anti-platelet aggregation medicines. The application of Aspeverin in preparation of anti-platelet aggregation medicines is disclosed for the first time, a framework type belongs to a brand-new framework type, the Aspeverin has an unexpected strong effect of inhibiting the platelet aggregation activity, and the revelation possibility of other compounds cannot be generated, so the application has obvious substantive features; and moreover, the application has an obvious improved effect of inhibiting the platelet aggregation. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107652305-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107629070-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107629070-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107459527-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107459527-B |
| priorityDate | 2013-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.